You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

empagliflozin

Showing 26 - 50 of 130
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Seoul (Teneligliptin, Empagliflozin, Teneligliptin and Empagliflozin)

Completed
  • Type 2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Clinical Pharmacology, Asan Medical Center
Nov 8, 2021

Combines Data From 3 Other Studies Testing Empagliflozin in

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • Empagliflozin
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Based on Data From German Sick Funds That Looks at Costs of

Completed
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • +3 more
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Heart Failure, Diastolic, Diabetes, Type 2 Trial in Moscow (Empagliflozin, Standard care)

Completed
  • Heart Failure, Diastolic
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Standard care
  • Moscow, Russian Federation
    National Medical Research Center for Cardiology
Jan 10, 2022

Type II Diabetes, Efficacy, Self, Safety Issues Trial in Islamabad (Empagliflozin)

Active, not recruiting
  • Type II Diabetes Mellitus
  • +2 more
  • Empagliflozin
  • Islamabad, Pakistan
    Umar Diabetes Foundation
Dec 20, 2021

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Tricuspid Regurgitation, Right Ventricular Dilatation Trial in Seoul (Carvedilol+Empagliflozin, Carvedilol, Empagliflozin)

Recruiting
  • Tricuspid Regurgitation
  • Right Ventricular Dilatation
  • Seoul, Korea, Republic of
  • +2 more
Feb 14, 2022

Type 2 Diabetes, Dyslipidemia Trial (BERLIM 25/10 association, EMPAGLIFLOZIN, ROSUVASTATIN CALCIUM)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • Dyslipidemia
  • BERLIM 25/10 association
  • +5 more
  • (no location specified)
Aug 3, 2022

Diabetes, Type 2 Trial in Japan (Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Placebo
  • Aichi, Nagoya, Japan
  • +17 more
Aug 23, 2022

End Stage Renal Disease Trial in Pisa (Empagliflozin, Placebo)

Completed
  • End Stage Renal Disease
  • Empagliflozin
  • Placebo
  • Pisa, Italy
    Department of Endocrinology and Metabolism, University of Pisa
Sep 13, 2021

Liver Diseases, Hypertension, Portal Trial in Wien, Montreal (BI 685509, Empagliflozin)

Recruiting
  • Liver Diseases
  • Hypertension, Portal
  • BI 685509
  • Empagliflozin
  • Pasadena, California
  • +27 more
Jan 24, 2023

Transthyretin Amyloid Cardiomyopathy Trial in New York (Empagliflozin)

Recruiting
  • Transthyretin Amyloid Cardiomyopathy
  • Empagliflozin
  • New York, New York
    Columbia University Irving Medical Center / NewYork-Presbyterian
Mar 15, 2022

type1diabetes Trial in Columbus (Empagliflozin)

Not yet recruiting
  • type1diabetes
  • Empagliflozin
  • Columbus, Ohio
    Ohio State University
Jun 7, 2021

Find Out How Many People With Type 2 Diabetes Had Cardiovascular

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Empagliflozin
  • Stockholm, Sweden
    Boehringer Ingelheim AB
Jul 21, 2021

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Chronic Heart Failure, Acute Decompensated Heart Failure, Diabetes Trial in Giza (Canagliflozin)

Recruiting
  • Chronic Heart Failure
  • +2 more
  • Giza, Egypt
    National heart institute
Oct 11, 2022

Glucose 6 Phosphatase Deficiency Trial in Warsaw (Empagliflozin)

Not yet recruiting
  • Glucose 6 Phosphatase Deficiency
  • Empagliflozin
  • Warsaw, Poland
    The Children's Memorial Health Institute
Jun 18, 2021

Diabetes, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD Trial in Karachi (Pioglitazone, Empagliflozin, Pioglitazone +

Recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Karachi, Sindh, Pakistan
    Aga Khan University Hospital
Mar 17, 2022

Type 2 Diabetes Trial in Karachi (Empagliflozin, Vildagliptin)

Completed
  • Type 2 Diabetes
  • Karachi, Sindh, Pakistan
    Department of Diabetes and Endocrinology at Sindh Government Hos
Apr 28, 2022

Heart Failure Trial in Oxford (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Empagliflozin
  • Placebo
  • Oxford, United Kingdom
    John Radcliffe Hospital
May 26, 2021

Diabetes, Type 2 Trial in Hellerup (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Placebo
  • Hellerup, Denmark
    Center for Diabetes Research, Gentofte Hospital
Jun 9, 2021

Atrial Fibrillation, Heart Failure, Obesity Trial in Acquaviva Delle Fonti (Empagliflozin, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • +3 more
  • Empagliflozin
  • Placebo
  • Acquaviva Delle Fonti, Bari, Italy
    Miulli General Hospital
Apr 1, 2021

Cardiovascular Diseases, Left Ventricular Hypertrophy Trial in Toronto, Keelung (Empagliflozin, Placebo)

Recruiting
  • Cardiovascular Diseases
  • Left Ventricular Hypertrophy
  • Empagliflozin
  • Placebo
  • Toronto, Ontario, Canada
  • +3 more
Jun 14, 2021

Based on Data From German Registries That Looks at

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Mahlow, Germany
    Diabetes Agenda 2010 GmbH
Mar 26, 2021

Diabetes, Type 2 Trial in China (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Empagliflozin
  • Placebo
  • Beijing, China
  • +23 more
Mar 21, 2022